Characterization of prostaglandin E receptors in canine small intestine using [3H] prostaglandin E1 binding. 1992

R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
Immunoinflammatory Diseases Research, Searle, Skokie, IL 60077.

Prostaglandin E (PGE) receptors in canine small intestinal mucosal and muscle membrane preparations were labeled with [3H] PGE1. Saturable, high affinity binding of [3H] PGE1 was observed in both preparations. The density of binding sites (fmol/mg protein) was 39 for mucosal membranes and 60 for muscle membranes, with corresponding dissociation constants of 10.6 nM and 5.8 nM, respectively. [3H] PGE1 binding sites in both preparations showed stereospecificity and high affinity for natural PGE1 and PGE2, but not for I or F-type PGs. Synthetic PGEs such as misoprostol and enisoprost had lower affinity than PGE1 or PGE2. Several analogs of enisoprost bound weakly to the binding sites. A highly significant correlation (C.C. = 0.9) was demonstrated between mucosal and muscle binding potency for a series of enisoprost analogs. There was also a significant positive correlation between the receptor binding potency and rat diarrheagenic activity for these analogs. These results indicate that PGE receptors in canine intestinal mucosa and muscle can be directly studied with [3H] PGE1 binding. The mucosal and muscle PGE receptors may have similar ligand binding specificity. We speculate that these receptors are likely to be associated with the diarrheagenic activity of PGEs.

UI MeSH Term Description Entries
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D008297 Male Males
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
June 1989, Prostaglandins, leukotrienes, and essential fatty acids,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
September 1990, Prostaglandins, leukotrienes, and essential fatty acids,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
May 1980, European journal of pharmacology,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
August 1998, The Journal of pharmacology and experimental therapeutics,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
November 2013, Acta cirurgica brasileira,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
May 1976, The Journal of biological chemistry,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
August 1997, British journal of pharmacology,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
July 1987, The American journal of medicine,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
January 1991, Peptides,
R H Keith, and B S Tsai, and P W Collins, and W E Perkins, and R L Shone, and A F Gasiecki, and R G Bianchi, and R F Bauer
December 1973, Biochemical and biophysical research communications,
Copied contents to your clipboard!